Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers.
Journal: Diseases (Basel, Switzerland)
Published: March 14, 2022
A Phase I Clinical Trial of Trametinib in Combination with TAS-102 in Patients with Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild Type) Metastatic Colorectal Cancer.
Journal: Clinical colorectal cancer
Published: March 05, 2022
Locally advanced anal small cell carcinoma with durable complete response to chemoradiation followed by consolidation chemotherapy: case report and literature review.
Journal: Journal of gastrointestinal oncology
Published: July 21, 2021
MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway.
Journal: Clinical colorectal cancer
Published: September 22, 2020
Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: June 30, 2020
Checkpoint inhibition in advanced gastroesophageal cancer: clinical trial data, molecular subtyping, predictive biomarkers, and the potential of combination therapies.
Journal: Translational gastroenterology and hepatology
Published: February 23, 2019
Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma.
Journal: Case reports in oncological medicine
Published: January 06, 2019
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade.
Journal: Clinical and translational medicine
Published: August 05, 2018
Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classification.
Journal: Journal of gastrointestinal oncology
Published: July 13, 2018
Moving Beyond Conventional Clinical Trial End Points in Treatment-refractory Metastatic Colorectal Cancer: A Composite Quality-of-life and Symptom Control End Point.
Journal: Clinical therapeutics
Published: May 31, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026